Christopher J. H. Porter

发表

Molecular modeling of lipid drug formulations

David K. Chalmers, Woldeamanuel A. Birru, Dallas B. Warren, 2012, Journal of Cheminformatics.

Computational prediction of formulation strategies for beyond-rule-of-5 compounds.

Christopher J. H. Porter, Christel A. S. Bergström, William N. Charman, 2016, Advanced drug delivery reviews.

From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity

Christopher J. H. Porter, L. Kaminskas, C. Porter, 2015, Nature Reviews Drug Discovery.

Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration.

Ben J. Boyd, Tracey Hanley, Christopher J. H. Porter, 2011, Journal of controlled release : official journal of the Controlled Release Society.

Drug Solubilization Behavior During in Vitro Digestion of Simple Triglyceride Lipid Solution Formulations

Ben J. Boyd, Christopher J. H. Porter, Ann Marie Kaukonen, 2004, Pharmaceutical Research.

A new in vitro lipid digestion – in vivo absorption model to evaluate the mechanisms of drug absorption from lipid-based formulations

Christopher J. H. Porter, Colin W. Pouton, C. Pouton, 2015, Pharmaceutical Research.

Low Dose Lipid Formulations: Effects on Gastric Emptying and Biliary Secretion

Clive G. Wilson, Christopher J. H. Porter, C. Porter, 2007, Pharmaceutical Research.

Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief

Pierangelo Geppetti, Martin J. Scanlon, Christopher J. H. Porter, 2017, Science Translational Medicine.

Tools for Early Prediction of Drug Loading in Lipid-Based Formulations

Christopher J. H. Porter, Christel A. S. Bergström, Linda C. Alskär, 2015, Molecular pharmaceutics.

Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations. 5. Lipolysis of Representative Formulations by Gastric Lipase

Anette Müllertz, Vincent Jannin, Christopher J. H. Porter, 2014, Pharmaceutical Research.

Intestinal Lymphatic Transport Enhances the Post-Prandial Oral Bioavailability of a Novel Cannabinoid Receptor Agonist Via Avoidance of First-Pass Metabolism

Christopher J. H. Porter, David M. Shackleford, G. Edwards, 2009, Pharmaceutical Research.

An in vitro examination of the impact of polyethylene glycol 400, pluronic P85, and vitamin E d-a-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine

Christopher J. H. Porter, C. Porter, W. Charman, 2002, AAPS PharmSci.

Lipid-Based Formulations and Drug Supersaturation: Harnessing the Unique Benefits of the Lipid Digestion/Absorption Pathway

Christopher J. H. Porter, Colin W. Pouton, C. Pouton, 2013, Pharmaceutical Research.

Minimum information reporting in bio–nano experimental literature

Edmund J. Crampin, Molly M. Stevens, Wolfgang J. Parak, 2018, Nature Nanotechnology.

Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission

Pierangelo Geppetti, Christopher J. H. Porter, Zhijian Cai, 2017, Proceedings of the National Academy of Sciences.

years of oral lipid-based formulations : Provenance , progress and future perspectives ☆

Christopher J. H. Porter, Colin W. Pouton, Christel A. S. Bergström, 2016 .

Susceptibility to Lipase-Mediated Digestion Reduces the Oral Bioavailability of Danazol After Administration as a Medium-Chain Lipid-Based Microemulsion Formulation

Ben J. Boyd, Christopher J. H. Porter, Ann Marie Kaukonen, 2004, Pharmaceutical Research.

Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers.

Christopher J. H. Porter, C. Porter, Lisa M. Kaminskas, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome

Brian L. Schmidt, Rocco Latorre, Christopher J. H. Porter, 2018, Proceedings of the National Academy of Sciences.

Lipid Absorption Triggers Drug Supersaturation at the Intestinal Unstirred Water Layer and Promotes Drug Absorption from Mixed Micelles

Christopher J. H. Porter, C. Porter, N. Trevaskis, 2013, Pharmaceutical Research.

Doxorubicin-conjugated PEGylated dendrimers show similar tumoricidal activity but lower systemic toxicity when compared to PEGylated liposome and solution formulations in mouse and rat tumor models.

Ben J. Boyd, Christopher J. H. Porter, Carleen Cullinane, 2012, Molecular pharmaceutics.

The Mechanism of Lymphatic Access of Two Cholesteryl Ester Transfer Protein Inhibitors (CP524,515 and CP532,623) and Evaluation of Their Impact on Lymph Lipoprotein Profiles

Christopher J. H. Porter, R. Shanker, C. Porter, 2010, Pharmaceutical Research.

Intestinal Lymphatic Transport of Halofantrine Occurs After Oral Administration of a Unit-Dose Lipid-Based Formulation to Fasted Dogs

Christopher J. H. Porter, David M. Shackleford, G. Edwards, 2003, Pharmaceutical Research.